 The CE marked M2-PK Test is available in form of an ELISA test for quantitative results or as point of care test to receive results within minutes.Tumor M2-PK is also useful to diagnose lung cancer and better than SCC and NSE tumor markers.With renal cell carcinoma (RCC), the M2PK test has sensitivity of 66.7 percent for metastatic RCC and 27.5 percent for nonmetastatic RCC, but M2PK test cannot detect transitional cell carcinoma of the bladder, prostate cancer and benign prostatic hyperplasia.